Warning letter woes: Dr Reddy's expects FDA inspection of AP plant by year-end

USFDA had issued warning letter in November 2015 relating to Current Good Manufacturing Practice deviations at DR Reddy's API manufacturing facilities at Srikakulam.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OsdNlD
via IFTTT